课题基金 / 基金详情

A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma

A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
对低危 HPV 相关口咽鳞状细胞癌患者进行择期容量调整降阶梯放射治疗 (EVADER) 的 II 期单臂试验
批准号：
379719
负责人：
Parulekar Wendy R
金额：
$62.7万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-03-01 至 2024-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=379719&lang=en
关键词：
Cooperative Group De-Escalation Head And Neck Cancer Human Papillomavirus Multi-Institutional Oropharynx Cancer Phase Ii Clinical Study Radiotherapy

项目摘要

项目成果

Parulekar Wendy R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Oropharyngeal squamous cell carcinoma (OPSCC) that is related to human papillomavirus (HPV) infection is increasing in incidence within Canada and worldwide. OPSCC is now the most common category of head and neck squamous cell carcinoma and the most commo
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimizing head and Neck Tumour And Symptom Control in Patients Unable to Tolerate Curative (Radio)Therapy: a Phase III trial Comparing Stereotactic Body Radiation Therapy (SBRT) to Standard Palliative Radiation Treatment (ON-TASC Study)
RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials - The MMRD-GREEN trial
SPECT-CT Guided ELEctive Contralateral Neck Treatment (SELECT) for Patients with Lateralized Oropharyngeal Cancer: A Phase III Randomized Controlled Trial
A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
海外基金